Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TriSalus Life Sciences (TLSI) EBT Margin (2022 - 2025)

TriSalus Life Sciences (TLSI) has 4 years of EBT Margin data on record, last reported at 73.86% in Q4 2025.

  • For Q4 2025, EBT Margin rose 4851.0% year-over-year to 73.86%; the TTM value through Dec 2025 reached 86.86%, up 1516.0%, while the annual FY2025 figure was 86.86%, 1520.0% up from the prior year.
  • EBT Margin reached 73.86% in Q4 2025 per TLSI's latest filing, up from 93.43% in the prior quarter.
  • Across five years, EBT Margin topped out at 27.44% in Q3 2023 and bottomed at 1374.34% in Q4 2022.
  • Average EBT Margin over 4 years is 259.85%, with a median of 113.12% recorded in 2025.
  • Peak YoY movement for EBT Margin: soared 75041bps in 2023, then tumbled -6092bps in 2025.
  • A 4-year view of EBT Margin shows it stood at 1374.34% in 2022, then skyrocketed by 55bps to 623.93% in 2023, then surged by 80bps to 122.37% in 2024, then surged by 40bps to 73.86% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 73.86% in Q4 2025, 93.43% in Q3 2025, and 73.94% in Q2 2025.